34LBA Fosaprepitant for the prevention of nausea and emesis during five weeks of chemo-radiotherapy: A multinational randomised, placebo-controlled, double-blind trial – the GAND-emesis study. (September 2015) - Ruhlmann, C.H.; Christensen, T.B.; Dohn, L.H.; Paludan, M.; Rannengart, E.; Hilpert, F.; Feyer, P.; Kristensen, G.; Keefe, D.; Hansen, O.; Herrstedt, J.